M
Michael J. Mack
Researcher at Scott & White Hospital
Publications - 634
Citations - 36680
Michael J. Mack is an academic researcher from Scott & White Hospital. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 89, co-authored 519 publications receiving 28877 citations. Previous affiliations of Michael J. Mack include Baylor University Medical Center & Medical City Dallas Hospital.
Papers
More filters
Journal ArticleDOI
Surgical Explantation of Failed Transcatheter Aortic Valve Replacement.
Syed Zaid,Sameer A. Hirji,Vinayak Bapat,Paolo Denti,Thomas Modine,Tom C. Nguyen,Michael J. Mack,Michael J. Reardon,Tsuyoshi Kaneko,Gilbert H.L. Tang +9 more
TL;DR: In this paper , the authors evaluated the short and mid-term risk of concomitant cardiac surgery at the time of TAVR-explant and found that concomitant-SAVR is associated with increased mortality.
Book ChapterDOI
Transcatheter Aortic Valve Therapies
Mohanad Hamandi,Michael J. Mack +1 more
TL;DR: This chapter provides an overview of the evidence base, current technology, guidelines and challenging issues related to TAVI.
Posted ContentDOI
Comparison of Transcatheter Edge-to-Edge Mitral Valve Repair for Primary Mitral Regurgitation Outcomes to Hospital Volumes of Surgical Mitral Valve Repair.
Paul A. Grayburn,Michael J. Mack,Pratik Manandhar,Adam Kosiński,Angela Sannino,R. Smith,Molly Szerlip,S Vemulapalli +7 more
TL;DR: In this article , a generalized linear mixed model was used to evaluate risk-adjusted in-hospital/30-day mortality, 30 day HF readmission and TEER success (MR [≤] 2+ and gradient < 5 mmHg).
Journal ArticleDOI
Impact of left ventricular ejection fraction on 10-year mortality in the SYNTAX trial.
Shinichiro Masuda,Patrick W. Serruys,Kai Ninomiya,Shigetaka Kageyama,Kotoku Nozomi,Chao Gao,Michael J. Mack,David R. Holmes,Marie-Claude Morice,Daniel J F M Thuijs,Milan Milojevic,Piroze M. Davierwala,Scot Garg,Yoshinobu Onuma +13 more
TL;DR: In this paper , the authors investigated the impact of LVEF at baseline on 10-year mortality in the SYNTAX trial, and found that reduced left ventricular ejection fraction (LVEF) was associated with an increased risk of death in patients revascularized either surgically or percutaneously.
Journal ArticleDOI
Impact of periprocedural major adverse events on 10-year mortality after revascularisation.
Nozomi Kotoku,Patrick W. Serruys,Kai Ninomiya,Alan Soo,Shinichiro Masuda,Shigetaka Kageyama,Pruthvi C Revaiah,Michael J. Mack,David R. Holmes,Marie-Claude Morice,Piroze M. Davierwala,Friedrich W. Mohr,Milan Milojevic,A. Pieter Kappetein,Scot Garg,Yoshinobu Onuma +15 more
TL;DR: In this article , the impact of periprocedural major adverse events (PMAE) following revascularisation for patients with complex coronary artery disease (CAD) has not yet been established.